Skip to content

ALPS

ALPS Group, Inc.

NASDAQ · Healthcare · Biotechnology · MY

$0.33
−2.41%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-4.92x
Price / sales
11.37x
Price / cash flow
-21.44x

Enterprise value

Enterprise value
$60.8M
EV / sales
12.51x
EV / EBITDA
-67.42x
EV / EBIT
-17.97x
Market cap
$55.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026